Latest Insider Transactions at Applied Therapeutics Inc. (APLT)
This section provides a real-time view of insider transactions for Applied Therapeutics Inc. (APLT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Applied Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Applied Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 11
2023
|
Adam Hansard Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,495
-4.64%
|
$0
$0.91 P/Share
|
|
Jan 11
2023
|
Riccardo Perfetti Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
550,000
+43.83%
|
-
|
|
Jan 11
2023
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,053
-3.76%
|
$0
$0.91 P/Share
|
|
Jan 11
2023
|
Shoshana Shendelman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,964,362
+41.97%
|
-
|
|
Jan 11
2023
|
Shoshana Shendelman President and CEO |
SELL
Open market or private sale
|
Direct |
15,870
-2.07%
|
$0
$0.91 P/Share
|
|
Nov 15
2022
|
Steven A. Ortega Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+41.93%
|
-
|
|
Oct 14
2022
|
Shoshana Shendelman President and CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+6.12%
|
$0
$0.64 P/Share
|
|
Oct 13
2022
|
Shoshana Shendelman President and CEO |
BUY
Open market or private purchase
|
Direct |
73,256
+9.26%
|
$0
$0.56 P/Share
|
|
Oct 12
2022
|
Shoshana Shendelman President and CEO |
BUY
Open market or private purchase
|
Direct |
38,153
+5.59%
|
$0
$0.52 P/Share
|
|
Sep 14
2022
|
Joel S Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
38,244
+2.28%
|
$38,244
$1.05 P/Share
|
|
Jun 27
2022
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,500,000
+34.41%
|
$3,500,000
$1.0 P/Share
|
|
May 16
2022
|
Chids Mahadevan Officer |
SELL
Open market or private sale
|
Direct |
905
-8.45%
|
$905
$1.65 P/Share
|
|
Apr 13
2022
|
Chids Mahadevan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+16.63%
|
-
|
|
Apr 13
2022
|
Steven A. Ortega Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,081
+16.67%
|
-
|
|
Mar 23
2022
|
Riccardo Perfetti Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+15.71%
|
$30,000
$1.97 P/Share
|
|
Mar 22
2022
|
Riccardo Perfetti Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
21,961
+14.37%
|
$21,961
$1.98 P/Share
|
|
Mar 21
2022
|
Riccardo Perfetti Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
12,548
+10.33%
|
$12,548
$1.85 P/Share
|
|
Feb 23
2022
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
300,000
-24.12%
|
-
|
|
Feb 23
2022
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
300,000
+10.75%
|
-
|
|
Jan 07
2022
|
Adam Hansard Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+24.64%
|
-
|
|
Jan 07
2022
|
Riccardo Perfetti Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,200
+33.33%
|
-
|
|
Jan 07
2022
|
Shoshana Shendelman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
120,900
+16.63%
|
-
|
|
Jan 07
2022
|
Charles Silberstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,900
+20.69%
|
-
|
|
Dec 14
2021
|
Charles Silberstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,900
+26.09%
|
-
|
|
Dec 14
2021
|
Adam Hansard Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+32.69%
|
-
|
|
Dec 14
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,200
+50.0%
|
-
|
|
Dec 14
2021
|
Shoshana Shendelman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
120,900
+19.95%
|
-
|
|
Sep 14
2021
|
Shoshana Shendelman President and CEO |
BUY
Open market or private purchase
|
Direct |
9,300
+2.49%
|
$130,200
$14.49 P/Share
|
|
Sep 13
2021
|
Shoshana Shendelman President and CEO |
BUY
Open market or private purchase
|
Direct |
701
+0.2%
|
$9,814
$14.69 P/Share
|
|
Aug 10
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
800
-100.0%
|
$12,800
$16.35 P/Share
|
|
Aug 10
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Open market or private sale
|
Direct |
8,273
+93.24%
|
$124,095
$15.85 P/Share
|
|
Aug 10
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
8,873
-50.0%
|
$8,873
$1.44 P/Share
|
|
Aug 09
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-84.33%
|
$255,000
$17.52 P/Share
|
|
Aug 09
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.44 P/Share
|
|
Jul 29
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$255,000
$17.18 P/Share
|
|
Jul 29
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.44 P/Share
|
|
Jul 28
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$255,000
$17.5 P/Share
|
|
Jul 28
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.44 P/Share
|
|
Jul 27
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-75.92%
|
$255,000
$17.22 P/Share
|
|
Jul 27
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.44 P/Share
|
|
Jul 15
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,740
$19.54 P/Share
|
|
Jul 15
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Jul 14
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$9,200
$20.51 P/Share
|
|
Jul 14
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
460
-50.0%
|
$460
$1.44 P/Share
|
|
Jul 13
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$9,660
$21.25 P/Share
|
|
Jul 13
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Jun 30
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-67.39%
|
$9,660
$21.25 P/Share
|
|
Jun 30
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Jun 29
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$9,660
$21.76 P/Share
|
|
Jun 29
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|